JESSE DENARDIN: Open Payments
NPI 1114653250 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,132 in 43 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $42 · 2025 $1,132
Food & beverage: $1,132
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $188 |
| Exact Sciences Corporation | 3 | $167 |
| Astellas Pharma US Inc | 3 | $160 |
| PFIZER INC. | 4 | $124 |
| GlaxoSmithKline, LLC. | 5 | $92 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $82 |
| Corcept Therapeutics | 3 | $50 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $47 |
| Lilly USA, LLC | 2 | $47 |
| Mannkind Corporation | 1 | $38 |
Products named: The Cologuard Plus Collection Kit, Veozah, TRELEGY ELLIPTA, Kerendia, AIRSUPRA, FARXIGA, Korlym, BREZTRI.
Industry payments across NY — which companies pay providers there.
